CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Roche Holding AG - ROGz CFD

    289.6
    0.75%
    1.0
    Rendah: 289.1
    Tinggi: 291.5
    Market Trading Hours* (UTC) Open now
    Closes on Wednesday at 15:20

    Mon - Fri: 07:00 - 15:20

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 1.0
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.014885 %
    Charges from borrowed part ($-0.60)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.014885%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.007337 %
    Charges from borrowed part ($-0.29)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.007337%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang CHF
    Margin 20%
    Bursa efek Switzerland
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Roche Holding AG ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    Key Stats
    Prev. Close* 291.8
    Open* 291.4
    1-Year Change* -9.16%
    Day's Range* 289.1 - 291.5
    52 wk Range 256.05-335.85
    Average Volume (10 days) 1.58M
    Average Volume (3 months) 28.15M
    Market Cap 238.76B
    P/E Ratio 19.02
    Shares Outstanding 799.18M
    Revenue 63.28B
    EPS 15.36
    Dividend (Yield %) 3.25175
    Beta 0.75
    Next Earnings Date Jul 27, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 6, 2023 291.8 1.0 0.34% 290.8 292.5 289.7
    Jun 5, 2023 291.7 -1.0 -0.34% 292.7 293.0 291.1
    Jun 2, 2023 292.1 3.1 1.07% 289.0 292.3 287.9
    Jun 1, 2023 288.6 0.6 0.21% 288.0 290.0 286.8
    May 31, 2023 284.1 -5.0 -1.73% 289.1 290.6 280.8
    May 30, 2023 288.2 -0.9 -0.31% 289.1 290.2 286.7
    May 26, 2023 290.7 1.6 0.55% 289.1 291.2 286.7
    May 25, 2023 287.4 0.8 0.28% 286.6 288.7 285.9
    May 24, 2023 288.2 1.2 0.42% 287.0 288.8 286.3
    May 23, 2023 285.8 0.4 0.14% 285.4 287.8 284.5
    May 22, 2023 285.7 -1.8 -0.63% 287.5 288.4 283.9
    May 19, 2023 287.1 2.1 0.74% 285.0 288.7 283.9
    May 17, 2023 283.5 1.4 0.50% 282.1 284.5 281.9
    May 16, 2023 281.6 -1.7 -0.60% 283.3 284.0 280.8
    May 15, 2023 284.2 -0.7 -0.25% 284.9 285.5 283.1
    May 12, 2023 283.9 2.0 0.71% 281.9 284.9 281.9
    May 11, 2023 281.5 1.0 0.36% 280.5 283.1 280.4
    May 10, 2023 280.2 -1.8 -0.64% 282.0 282.0 278.8
    May 9, 2023 282.9 -1.1 -0.39% 284.0 284.5 281.0
    May 8, 2023 283.7 0.3 0.11% 283.4 285.0 282.8

    Roche Holding AG Events

    Time (UTC) Country Event
    Thursday, June 8, 2023

    Time (UTC)

    06:00

    Country

    CH

    Event

    Roche Holding AG at Exane CEO Conference
    Roche Holding AG at Exane CEO Conference

    Forecast

    -

    Previous

    -
    Monday, June 12, 2023

    Time (UTC)

    14:30

    Country

    CH

    Event

    Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology
    Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology

    Forecast

    -

    Previous

    -
    Wednesday, June 14, 2023

    Time (UTC)

    12:00

    Country

    CH

    Event

    Roche Holding AG at Stifel Swiss Equities Conference
    Roche Holding AG at Stifel Swiss Equities Conference

    Forecast

    -

    Previous

    -

    Time (UTC)

    15:00

    Country

    CH

    Event

    Roche Holding AG at Goldman Sachs Healthcare Conference
    Roche Holding AG at Goldman Sachs Healthcare Conference

    Forecast

    -

    Previous

    -
    Tuesday, June 20, 2023

    Time (UTC)

    07:00

    Country

    CH

    Event

    Roche Holding AG at Citi European Healthcare Conference
    Roche Holding AG at Citi European Healthcare Conference

    Forecast

    -

    Previous

    -
    Wednesday, June 21, 2023

    Time (UTC)

    08:00

    Country

    CH

    Event

    Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian Conference
    Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian Conference

    Forecast

    -

    Previous

    -
    Thursday, June 22, 2023

    Time (UTC)

    07:00

    Country

    CH

    Event

    Roche Holding AG at JPMorgan European Healthcare Conference
    Roche Holding AG at JPMorgan European Healthcare Conference

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 63281 62801 58323 61466 56846
    Revenue 63281 62801 58323 61466 56846
    Cost of Revenue, Total 18511 19348 15900 17377 16445
    Gross Profit 44770 43453 42423 44089 40401
    Total Operating Expense 45805 44646 39780 43918 42077
    Selling/General/Admin. Expenses, Total 12124 12100 12075 13208 12453
    Research & Development 14050 13707 12151 11690 11048
    Depreciation / Amortization 378 351 446 268 183
    Unusual Expense (Income) 2569 376 426 2677 3945
    Other Operating Expenses, Total -1827 -1236 -1218 -1302 -1997
    Operating Income 17476 18155 18543 17548 14769
    Interest Income (Expense), Net Non-Operating -1040 -677 -463 -758 -419
    Other, Net -109 -80 -115 -176 -202
    Net Income Before Taxes 16327 17398 17965 16614 14148
    Net Income After Taxes 13531 14935 15068 14108 10830
    Minority Interest -1110 -1005 -773 -611 -365
    Net Income Before Extra. Items 12421 13930 14295 13497 10465
    Net Income 12421 13930 14295 13497 10500
    Income Available to Common Excl. Extra. Items 12421 13930 14295 13497 10465
    Income Available to Common Incl. Extra. Items 12421 13930 14295 13497 10500
    Dilution Adjustment -1 -1 -1 -2 -1
    Diluted Net Income 12420 13929 14294 13495 10499
    Diluted Weighted Average Shares 808 860 865 864 860
    Diluted EPS Excluding Extraordinary Items 15.3713 16.1965 16.5249 15.6192 12.1674
    Dividends per Share - Common Stock Primary Issue 9.5 9.3 9.1 9 8.7
    Diluted Normalized EPS 17.9847 16.5778 16.9515 18.2807 15.702
    Total Extraordinary Items 35
    Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 30986 32295 32088 30713
    Revenue 30986 32295 32088 30713
    Cost of Revenue, Total 8949 9562 10279 9069
    Gross Profit 22037 22733 21809 21644
    Total Operating Expense 25057 20748 24010 20636
    Selling/General/Admin. Expenses, Total 6479 5645 6544 5556
    Research & Development 7422 6628 7017 6690
    Depreciation / Amortization 196 182 177 174
    Unusual Expense (Income) 2584 -15 619 -243
    Other Operating Expenses, Total -573 -1254 -626 -610
    Operating Income 5929 11547 8078 10077
    Interest Income (Expense), Net Non-Operating -568 -472 -524 -151
    Other, Net -19 -90 -43 -39
    Net Income Before Taxes 5342 10985 7511 9887
    Net Income After Taxes 4370 9161 6719 8216
    Minority Interest -479 -631 -592 -413
    Net Income Before Extra. Items 3891 8530 6127 7803
    Net Income 3891 8530 6127 7803
    Income Available to Common Excl. Extra. Items 3891 8530 6127 7803
    Income Available to Common Incl. Extra. Items 3891 8530 6127 7803
    Dilution Adjustment -1 0 -1 0
    Diluted Net Income 3890 8530 6126 7803
    Diluted Weighted Average Shares 806 810 858 862
    Diluted EPS Excluding Extraordinary Items 4.8263 10.5309 7.13986 9.0522
    Dividends per Share - Common Stock Primary Issue 9.5 0 9.3 0
    Diluted Normalized EPS 7.42355 10.5195 7.78732 8.8218
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 33816 35627 32942 31254 32244
    Cash and Short Term Investments 9767 13031 12334 11858 13118
    Cash 2841 5028 4536 4769 4139
    Cash & Equivalents 2150 1822 1191 1306 2542
    Short Term Investments 4776 6181 6607 5783 6437
    Total Receivables, Net 13866 12651 11740 12150 11487
    Accounts Receivable - Trade, Net 11527 10719 10056 10343 9687
    Total Inventory 8605 7715 7194 6055 6621
    Prepaid Expenses 1202 1869 1153 795 683
    Other Current Assets, Total 376 361 521 396 335
    Total Assets 88151 92317 86138 83091 78517
    Property/Plant/Equipment, Total - Net 24208 24412 23270 23318 21818
    Property/Plant/Equipment, Total - Gross 49408 48205 45664 45041 41822
    Accumulated Depreciation, Total -25200 -23793 -22394 -21723 -20004
    Goodwill, Net 10820 10809 9249 12456 8948
    Intangibles, Net 9685 12117 12017 8358 9346
    Long Term Investments 971 1069 1276 739 602
    Note Receivable - Long Term 125 133 125 128 132
    Other Long Term Assets, Total 8526 8150 7259 6838 5427
    Total Current Liabilities 27239 38416 25401 24119 23033
    Accounts Payable 3861 3844 3317 3176 2847
    Accrued Expenses 12180 12497 11205 11214 10676
    Notes Payable/Short Term Debt 2191 14618 2189 1694 722
    Current Port. of LT Debt/Capital Leases 2071 833 2126 341 1971
    Other Current Liabilities, Total 6936 6624 6564 7694 6817
    Total Liabilities 60159 67828 49797 50344 50895
    Total Long Term Debt 22282 17101 11096 13547 16077
    Long Term Debt 21391 16076 10220 12668 16075
    Capital Lease Obligations 891 1025 876 879 2
    Deferred Income Tax 645 628 353 298 384
    Minority Interest 4023 3856 3432 3120 2744
    Other Liabilities, Total 5970 7827 9515 9260 8657
    Total Equity 27992 24489 36341 32747 27622
    Common Stock 107 160 160 160 160
    Retained Earnings (Accumulated Deficit) 38937 34161 45571 40524 34935
    Unrealized Gain (Loss) -59 -60 106 15 28
    Other Equity, Total -10993 -9772 -9496 -7952 -7501
    Total Liabilities & Shareholders’ Equity 88151 92317 86138 83091 78517
    Total Common Shares Outstanding 799.181 800.403 853.126 855.756 854.428
    Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 33816 30321 35627 31260
    Cash and Short Term Investments 9767 6808 13031 8017
    Cash & Equivalents 4991 4315 6850 5000
    Short Term Investments 4776 2493 6181 3017
    Total Receivables, Net 11919 11078 11126 11809
    Accounts Receivable - Trade, Net 11606 10809 10806 11656
    Total Inventory 8605 8292 7715 8319
    Other Current Assets, Total 3525 4143 3755 3115
    Total Assets 88151 86736 92317 87887
    Property/Plant/Equipment, Total - Net 24208 24324 24412 24300
    Goodwill, Net 10820 11160 10809 10623
    Intangibles, Net 9685 11735 12117 12510
    Other Long Term Assets, Total 9622 9196 9352 9194
    Total Current Liabilities 27239 27409 38416 25193
    Payable/Accrued 4556 3896 4637 4241
    Notes Payable/Short Term Debt 2191 2976 14618 2530
    Current Port. of LT Debt/Capital Leases 1769 2405 504 1196
    Other Current Liabilities, Total 18723 18132 18657 17226
    Total Liabilities 60159 61547 67828 50073
    Total Long Term Debt 21391 22369 16076 11285
    Long Term Debt 21391 22369 16076 11285
    Deferred Income Tax 645 690 628 499
    Minority Interest 4023 3757 3856 3619
    Other Liabilities, Total 6861 7322 8852 9477
    Total Equity 27992 25189 24489 37814
    Common Stock 107 107 160 160
    Retained Earnings (Accumulated Deficit) 38937 35740 34161 46686
    Unrealized Gain (Loss) -59 -151 -60 -90
    Other Equity, Total -10993 -10507 -9772 -8942
    Total Liabilities & Shareholders’ Equity 88151 86736 92317 87887
    Total Common Shares Outstanding 799.181 800.579 800.403 854.261
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 13531 14935 15068 14108 10865
    Cash From Operating Activities 18415 20976 18566 22385 19979
    Cash From Operating Activities 2906 2887 2808 2760 2292
    Amortization 938 1556 1750 1532 1294
    Non-Cash Items 9267 7718 6227 8883 10308
    Cash Taxes Paid 4102 3343 3236 3543 3288
    Cash Interest Paid 557 407 422 624 593
    Changes in Working Capital -8227 -6120 -7287 -4898 -4780
    Cash From Investing Activities -3536 -6552 -9067 -8634 -7195
    Capital Expenditures -4797 -4652 -7858 -4896 -6746
    Other Investing Cash Flow Items, Total 1261 -1900 -1209 -3738 -449
    Cash From Financing Activities -16275 -13108 -9666 -14173 -10691
    Financing Cash Flow Items -2340 -2333 -1992 -1716 -3316
    Total Cash Dividends Paid -7832 -8132 -7964 -7682 -7253
    Issuance (Retirement) of Debt, Net -6103 16348 290 -4775 -122
    Foreign Exchange Effects -463 -193 -181 -184 -131
    Net Change in Cash -1859 1123 -348 -606 1962
    Issuance (Retirement) of Stock, Net 0 -18991
    Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Net income/Starting Line 13531 9161 14935 8216
    Cash From Operating Activities 18415 9509 20976 8212
    Cash From Operating Activities 2906 1429 2887 1439
    Amortization 938 471 1556 830
    Non-Cash Items 9267 3799 7718 3323
    Cash Taxes Paid 4102 2482 3343 2183
    Cash Interest Paid 557 228 407 243
    Changes in Working Capital -8227 -5351 -6120 -5596
    Cash From Investing Activities -3536 1473 -6552 44
    Capital Expenditures -4797 -2067 -4652 -2197
    Other Investing Cash Flow Items, Total 1261 3540 -1900 2241
    Cash From Financing Activities -16275 -13315 -13108 -9056
    Financing Cash Flow Items -2340 -1374 -2333 -1211
    Total Cash Dividends Paid -7832 -7672 -8132 -7955
    Issuance (Retirement) of Debt, Net -6103 -4269 16348 110
    Foreign Exchange Effects -463 -202 -193 73
    Net Change in Cash -1859 -2535 1123 -727
    Issuance (Retirement) of Stock, Net 0 -18991
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1087 21840391 178848 2023-04-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.8532 20045265 2208289 2022-12-31 LOW
    UBS Asset Management (Switzerland) Investment Advisor 1.8605 13071428 -39477 2023-04-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.8324 12873933 77580 2023-04-30 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 1.6652 11699069 7778 2023-04-30 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.5324 10765987 125180 2023-04-30 LOW
    Zürcher Kantonalbank (Asset Management) Bank and Trust 1.239 8704542 83328 2023-04-30 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.999 7018571 -33622 2023-04-30 LOW
    Fidelity International Investment Advisor 0.8386 5891865 51949 2023-04-30 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 0.6723 4723312 9296 2023-04-30 LOW
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.6582 4624038 664 2023-04-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 0.6079 4271039 22563 2023-04-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6058 4256225 28940 2023-04-30 LOW
    Dodge & Cox Investment Advisor/Hedge Fund 0.5908 4150400 75100 2023-03-31 LOW
    California Public Employees' Retirement System Pension Fund 0.5839 4102151 -453583 2022-06-30 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.4934 3466391 -1771057 2023-04-30 MED
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.4679 3287387 -5027 2023-04-30 LOW
    RBC Global Asset Management (UK) Limited Investment Advisor 0.4129 2900866 -94725 2023-04-30 LOW
    PRIMECAP Management Company Investment Advisor 0.3704 2602358 -25668 2023-03-31 LOW
    Mawer Investment Management Ltd. Investment Advisor 0.3591 2522750 3313 2023-03-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Pharmaceuticals (NEC)

    Grenzacherstrasse 124
    BASEL
    BASEL-STADT 4058
    CH

    Income Statement

    • Annual
    • Quarterly

    People also watch

    BTC/USD

    26,823.65 Price
    -0.450% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Oil - Crude

    72.55 Price
    +1.360% 1D Chg, %
    Biaya inap posisi Long -0.0179%
    Biaya inap posisi short -0.0040%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    XRP/USD

    0.53 Price
    +1.510% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00406

    US100

    14,579.80 Price
    +0.060% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda